Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Biricodar inhibitor

Peck, R.A., et al. 2001. Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin. J Clin Oncol 19 3130. [Pg.109]

Toppmeyer D, Seidman AD, Poliak M, Russell C, Tkaczuk K, Verma S, Overmoyer B, Garg V, Ette E, Harding MW, Demetri GD. Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar VX-710) in combination with pachtaxel for advanced breast cancer refractory to pachtaxel. Clin Cancer Res 2002 8 610 1%. [Pg.145]

Seiden MV, Swenerton KD, Matulonis U, Campos S, Rose P, Batist G et al. A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and pachtaxel in women with advanced ovarian cancer refractory to pachtaxel therapy. Gynecol Oncol 2002 86 302-310. [Pg.638]

See other pages where Biricodar inhibitor is mentioned: [Pg.95]    [Pg.402]    [Pg.127]    [Pg.95]    [Pg.490]    [Pg.497]   
See also in sourсe #XX -- [ Pg.402 ]



SEARCH



© 2024 chempedia.info